Flow cytometric analysis of estrogen receptor expression in isolated nuclei and cells from mammary cancer tissues

Cytometry

Volumn 36, Issue 2, 1999, Pages 131-139

  Sabe, Isam ^a   Andritsch, Ilia ^c   Mangoud, A ^a   Awad, A S ^a   Khalifa, A ^b   Krishan, Awtar ^c  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aneuploidy; DNA content; Estrogen receptor; Flow cytometry; Heterogeneity; Mammary tumors; Multiparametric analysis

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; PROGESTERONE; PROGESTERONE RECEPTOR; PROPIDIUM IODIDE; TRITON X 100;

ANEUPLOIDY; ARTICLE; BREAST CANCER; CELL NUCLEUS; CELL SUBPOPULATION; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; DNA; ENDOPEPTIDASES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; PROPIDIUM; RECEPTORS, ESTROGEN; STAINING AND LABELING; TISSUE FIXATION; TUMOR CELLS, CULTURED;

EID: 0033152814     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990601)36:2<131::AID-CYTO7>3.0.CO;2-U     Document Type: Article

References (36)

1. McGuire WL, Clark GM, Dressler LG, Owens MA. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 1986;1:19-23.
2. Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node-negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 1988;6:1076-1087.
3. [Anonymous]. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996;14:2843-2877.
4. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KSSR Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985;109:716-721.
5. Pari FF, Posey YF. Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer. Hum Pathol 1988;19:960-966.
6. Allred DC, Bustamante MA, Daniel CO, Gaskill HV, Cruz AB Jr. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and a review of the literature regarding concordance with the biochemical assay and clinical relevance. Arch Surg 1990;125:107-134.
7. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathological, demographic, and biochemical correlation and relationship to endocrine response and survival. Cancer 1990;66:1663-1670.
8. Allred DC. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer? Am J Clin Pathol 1993;99:1-2.
9. Kell DL, Kamel O, Rouse RV. Immunohistochemical analysis of breast carcinoma estrogen and progesterone receptors in paraffin-embedded tissue. Correlation of clones ER 1D5 and 1A6 with a cytosol-based hormone receptor assay. Appl Immunohistochem 1993;1:275-281.
10. Robertson JF, Cannon PM, Nicholson RI, Blamey RW. Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancer. Int J Biol Markers 1996;11:29-35.
11. Scheres HME, Schutte B, De Goij AFPM, Bosman FT. Estrogen and progesterone receptor expression and proliferation in breast cancer cells studied with flow cytometry. Acta Histochem 1990;5(suppl XL):71-75.
12. Remvikos Y, VuHai M, Laine-Bidron C, Jollivet A, Magdelenat H. Progesterone receptor detection and quantification in breast tumors by bivariate immunofluorescence/DNA flow cytometry. Cytometry 1991;12:157-166.
13. Schutte B, Scheres HME, De Goij AFPM, Rousch MJM, Blijham GH, Bosman FT, Ramaekers FCS. Flow cytometric steroid receptor analysis. Prog Histochem Cytochem 1992;26:68-76.
14. Brotherick I, Lennard TWJ, Cook S, Johnstone R, Angus B, Winthereik MP, Shenton BK. Use of the biotinylated antibody DAKO-ER 1D5 to measure estrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells. Cytometry 1995;70:74-80.
15. King WJ, Greene GL. Monoclonal antibodies localize estrogen receptor in the nuclei of target cells. Nature 1984;307:745-747.
16. Sumida C, Magdalenat H, Pasqualini JR. Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer. Breast Cancer Res Treatm 1985;5:165-169.
17. KuKuruga M, Tomur S, Johnson R, Tait L, Lee Y, Krishan A. Flow cytometric determination of estrogen receptor expression in human breast cancer cell lines [abstract 1535]. Proc AACR 1995;36:257.
18. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell by propidium iodide staining. J Cell Biol 1975;46:188-193.
19. Taylor IW. A rapid single step staining technique for DNA analysis using flow microfluorimetry. J Histochem Cytochem 1980;28:1021-1024.
20. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove E. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histchem Cytochem 1983;31:1333-1335.
21. Fossa SD, Berner A, Waehre H, Heiden T, Juul MEH, Ouden DVD, Pettersen EO, Wang N, Tribukait B. DNA Ploidy in cell nuclei from paraffin-embedded material: comparison of results from two laboratories. Cytometry 1992;13:395-403.
22. Macleod CB, Repetti CF, Tsokos M. Enzymatic treatments on paraffin blocks for DNA flow cytometry. Mod Pathol 1992;5:569-574.
23. Overton WR. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 1988;9:619-626.
24. Snedecor GW, Cochran WC. Statistical methods. 7th ed. Ames: Iowa State University Press: 1980. p 220-290.
25. Defranco DB, Madan AP, Tang Y, Chandran UR, Xiao N, Yang J. Nucleocytoplasmic shuttling of steroid receptors. Vit Hormones 1995;51:315-338.
26. Dako, Corp. Carpinteria, CA. Biotinylated monoclonal mouse anti-human estrogen receptor, 1D5 [product specification sheet]. Carpinteria (CA): Dako, Inc.; 1997.
27. Immunotech-Coulter. Miami, FL. Monoclonal antibody for progesterone receptor, 1A6 [data sheet]. Immunotech-Coulter; 1996.
28. Vindelov LL, Christensen IJ, Nissen NI. A detergent-tiypsin method for the preparing of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-327.
29. Kodama F, Green GL, Salmon SE. Relation of estrogen receptor expression to clonal growth and antiestrogen effects on human breast cancer cells. Cancer Res 1985;45:2720.
30. Jakesz R, Smith CA, Aitken S, Huff K, Schuette S, Lippman M. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res 1984;44:619.
31. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NSB, Gazet J-C, Nolan C, Coombes RC. Estrogen and progesterone receptors in the normal female breast. Cancer Res 1991;51:1817-1822.
32. Kute TE, Heidemann P, Wittliff JL. Molecular heterogeneity of cystolic forms of ostrogen receptors from human breast tumors. Cancer Res 1978;38:4307.
33. Heiden T, Wang N, Tribukait B. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase fraction. Cytometry 1991;12:614-621.
34. Lincoln ST, Bauer KD. Limitations in the measurement of C-myc oncoprotein and other nuclear antigens by flow cytometry. Cytometry 1989;10:456-462.
35. Redkar AA, Krishan A. Flow cytometric analysis of estrogen, progesterone receptor expression and DNA content in formalin fixed, paraffin embedded human breast tumors. Commun Clin Cytometry 1999. Forthcoming.
36. Overton WR, Catalano E, McCoy JP Jr. Method to make paraffin-embedded breast and lymph tissue mimic fresh tissue in DNA analysis. Cytometry 1996;26:166-171.